31 – 40 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025 : Results from Two Randomized Studies in Healthy Subjects
(
- Contribution to journal › Article
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
(
- Contribution to journal › Article
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
- 2020
-
Mark
Blood eosinophils : In quest of a Holy Grail for personalized asthma treatment with biologicals
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
(
- Contribution to journal › Letter
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
Clinical and daily respiratory care and clinical trials within the COVID-19 era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Editorial : Asthma: a modifiable disease on a crossroad
(
- Contribution to journal › Article
-
Mark
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
(
- Contribution to journal › Article
-
Mark
The need for clean air : The way air pollution and climate change affect allergic rhinitis and asthma
(
- Contribution to journal › Scientific review